Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.
Treatment advances have improved outcomes in patients with lung cancer, with a number of targeted therapies and immunotherapies now approved for patients with metastatic disease. Along with longer survival, modern treatment paradigms have increased therapeutic decision-making complexity underscoring informative imaging as paramount in guiding clinical care. In this review, we summarize challenges the thoracic oncologist encounters in common clinical settings. In addition, we explore unmet needs for future investigations with particular focus on positron emission tomography technology and immunotherapies.
Department of Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC.
Anastasios
A
Dimou
Carol
C
Sherman
John
J
Wrangle
D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008168:Lung / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D008495:Medical Oncology; D000072078:Positron Emission Tomography Computed Tomography; D049268:Positron-Emission Tomography / Q000379:methods*